ArticleAnnals of translational medicine2022

Chemotherapy modulates CDK4/6 inhibitors resistance in metastatic breast cancer by Rb1 mutations: a case report and literature review.

Lu Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.